miR-181 regulates cisplatin-resistant non-small cell lung cancer via downregulation of autophagy through the PTEN/PI3K/AKT pathway

MLA

Yingru Xing, et al. “MiR-181 Regulates Cisplatin-Resistant Non-Small Cell Lung Cancer via Downregulation of Autophagy through the PTEN/PI3K/AKT Pathway.” Oncology Reports, vol. 39, no. 4, Feb. 2018, pp. 1631–39. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....cb7224f4e07dcacb97a50b6d4d74b4c6&authtype=sso&custid=ns315887.

APA

Yingru Xing, Jiangang Liu, & Ling Rong. (2018). miR-181 regulates cisplatin-resistant non-small cell lung cancer via downregulation of autophagy through the PTEN/PI3K/AKT pathway. Oncology Reports, 39(4), 1631–1639.

Chicago

Yingru Xing, Jiangang Liu, and Ling Rong. 2018. “MiR-181 Regulates Cisplatin-Resistant Non-Small Cell Lung Cancer via Downregulation of Autophagy through the PTEN/PI3K/AKT Pathway.” Oncology Reports 39 (4): 1631–39. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....cb7224f4e07dcacb97a50b6d4d74b4c6&authtype=sso&custid=ns315887.